AlphaCrest Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-18,862
| Closed | -$2.51M | – | 583 |
|
|
2022
Q3 | $2.51M | Buy |
18,862
+11,089
| +143% | +$1.48M | 0.15% | 148 |
|
|
2022
Q2 | $1.21M | Buy |
+7,773
| New | +$1.21M | 0.06% | 579 |
|
|
2022
Q1 | – | Sell |
-17,631
| Closed | -$2.25M | – | 1330 |
|
|
2021
Q4 | $2.25M | Buy |
17,631
+4,942
| +39% | +$630K | 0.08% | 361 |
|
|
2021
Q3 | $1.65M | Buy |
12,689
+7,684
| +154% | +$1M | 0.09% | 387 |
|
|
2021
Q2 | $889K | Sell |
5,005
-324
| -6% | -$57.6K | 0.04% | 722 |
|
|
2021
Q1 | $876K | Buy |
+5,329
| New | +$876K | 0.05% | 554 |
|
|
2020
Q3 | – | Sell |
-5,448
| Closed | -$601K | – | 1145 |
|
|
2020
Q2 | $601K | Sell |
5,448
-8,748
| -62% | -$965K | 0.1% | 310 |
|
|
2020
Q1 | $1.42M | Buy |
14,196
+6,910
| +95% | +$689K | 0.17% | 158 |
|
|
2019
Q4 | $1.09M | Sell |
7,286
-10,260
| -58% | -$1.53M | 0.09% | 312 |
|
|
2019
Q3 | $2.25M | Buy |
17,546
+10,903
| +164% | +$1.4M | 0.14% | 189 |
|
|
2019
Q2 | $947K | Buy |
6,643
+1,225
| +23% | +$175K | 0.08% | 424 |
|
|
2019
Q1 | $775K | Buy |
5,418
+2,348
| +76% | +$336K | 0.12% | 278 |
|
|
2018
Q4 | $381K | Buy |
+3,070
| New | +$381K | 0.11% | 348 |
|